Drug addiction is a neuropsychiatric disorder characterized by attentional abnormalities whereby enhanced attention is afforded to drugs and drug-related cues at the expense of other (including intrinsically pleasant) reinforcers (e.g., food, sex or money).
Introduction
Drug addiction is a neuropsychiatric disorder characterized by attentional abnormalities whereby enhanced attention is afforded to drugs and drug-related cues at the expense of other (including intrinsically pleasant) reinforcers (e.g., food, sex or money). 1, 2 This attention bias toward drug-related cues is posited to result from conditioning to drug-related cues, which become excessively and motivationally salient through habitual use. 1, 3, 4 The underlying mechanism invokes changes to mesolimbic dopamine transmission, associated with an increased incentive salience that is automatically attributed to drug-related cues. 5, 6 Ultimately, this drug-related attention bias influences drug-seeking behaviour, which in turn is associated with increased craving [7] [8] [9] and relapse susceptibility. [10] [11] [12] [13] Abstinence from drug use improves cognitive and affective functioning, including attentional bias/ dysregulation, in drug-addicted individuals. 14 To objectively quantify attention to salient cues, several prior studies have used the late positive potential (LPP), an event-related potential (ERP) component that marks motivated attention to emotionally salient stimuli. 15, 16 Specifically, increased LPP amplitude in response to drug-related compared with neutral cues has consistently been shown across all substance use disorders [17] [18] [19] [20] [21] [22] [23] and has further been linked with cue-induced craving. 24 Importantly, cross-sectional studies have shown that the LPP amplitude to drug-related cues is decreased 25, 26 while that to non-drug-related cues is increased 19, 27 after a period of reduced drug use (3 d to about 1 yr). Moreover, prospective neuroimaging studies modelling relapse vulnerability and future drug use have shown that reduced attention toward drug-related cues 11, 12, [28] [29] [30] and increased attention toward non-drug-related reinforcers [31] [32] [33] predicted longer abstinence durations in individuals with substance use disorders. Although these studies are highly informative, many have been limited to the cross-sectional effects of shorter-term 19 or longer-term abstinence 25, 31 relying mostly on self-reported follow-up assessments. 12, [28] [29] [30] 32, 33 An exception is a longitudinal behavioural study that reported reduced attention bias to drug-related cues (assessed via an emotional Stroop task) in heroin-addicted individuals after 3 weeks of heroin abstinence. 11 Thus, a systematic withinsubjects longer-term longitudinal investigation that examines the effects of drug use reduction/abstinence on attention bias to drug-related compared with non-drug-related reinforcers is lacking.
The goal of the present study was to examine the effects of reduced drug use on LPP-indexed attention bias (to drug-related v. alternative pleasant stimuli) using a longitudinal pre-post design in initially abstinent treatment-seeking individuals with cocaine use disorders (CUD). We hypothesized that, compared with baseline, at 6-month follow-up (during which drug use was substantially reduced or eliminated) individuals with CUD would show decreased LPPs in response to drug-related images and increased LPPs to pleasant images, reflecting a reversal in relative attention bias. Furthermore, given prior reports, we predicted that this attention bias modulation would track with reduced drug craving and longer abstinence duration.
Methods

Participants
We recruited treatment-seeking individuals with CUD for participation in our study. They all completed the study procedures twice: at baseline after detoxification (≥ 3 wk after last drug use) and then again 6 months later. For comparison, we recruited matched healthy controls for scanning; unlike individuals with CUD who were scanned twice, controls were scanned only once (at baseline). To be included in the study, all participants were required to be native English speakers and free of sustained/ maintenance medications for more than 30 days prior and throughout the study. Exclusion criteria were history of head trauma or loss of consciousness (> 30 min) or other neurologic diseases of central origin (including seizures), current medical diseases that required hospitalization or regular monitoring, positive urine screens for psychoactive drugs or their metabolites (phencyclidine, benzodiazepines, cannabis, opiates, barbiturates and inhalants) other than cocaine, and verbal intelligence score more than 2 standard deviations below normal. Depression, ascertained via the Beck Depression Inventory, 34 and cigarette smoking status were assessed at baseline in all participants and at follow-up in those with CUD. All participants were fully informed of all study procedures and risks, and they provided written informed consent in accordance with the Stony Brook University Institutional Review Board and the associated treatment facility's Institutional Review Board. A detailed outline of recruitment sources is presented in Appendix 1, available at jpn.ca.
Our sample size, albeit relatively small, is consistent with the anticipated effect sizes in a longitudinal study examining attention bias in individuals with CUD. Specifically, prior crosssectional studies assessing attention to salient cues in using versus abstaining individuals with addition 19, [25] [26] [27] found effect sizes (Cohen d) that averaged 0.9. We determined that to detect effect sizes of this magnitude in a longitudinal study with 2 time points (baseline and follow-up) at a significance level of p < 0.05 and 80% power we would need a 10 participants per time point.
Diagnostic interview
We conducted a clinical diagnostic interview with all participants at baseline, consisting of the Structured Clinical Interview for DSM-IV axis I disorders; 38, 39 the Addiction Severity Index, 40 a semistructured interview instrument that assesses the severity as well as recent and lifetime history of alcohol-and drugrelated problems as they relate to 7 problem areas (medical, employment, legal, alcohol, other drug use, family-social functioning and psychological status); the 18-item Cocaine Selective Severity Assessment Scale, 41 designed to evaluate cocaine abstinence/withdrawal signs and symptoms (i.e., sleep impairment, anxiety, energy levels, craving, and depressive symptoms) within 24 hours of the interview; the 5-item Severity of Dependence Scale; 42 and the 5-item Cocaine Craving Questionnaire. 43 This interview determined that individuals with CUD met the criteria for current cocaine dependence or cocaine dependence in partial or sustained remission.
Abstinence assessment in individuals with CUD
To characterize our treatment-seeking sample, we tracked participants' abstinence from baseline to follow-up using a 3-tiered system. 35 First, we made monthly phone calls to all individuals with CUD and their designated collaterals (e.g., family member, counselor); for those participants who remained in residential care for the duration of the 6-month study, we consulted the treatment centre (Samaritan Village) directly. At follow-up, participants completed the Timeline Follow-back Calendar (CL-90), 36 a retrospective calendar that assesses drug use (including number of days and amount used) in the past 90 days. Finally, also at follow-up, we collected retrospective data regarding last date of cocaine use. Participants were informed about the importance of reliable self-reporting, and they had no incentive for denial or biased reporting since neither inclusion into the study nor compensation were contingent on abstinence. Nevertheless, there was a discrepancy between 1 participant self-report (reporting abstinence) and a collateral report (reporting probable cocaine use); as a conservative measure, we coded this participant as having used cocaine.
Study procedures
On each visit, participants underwent electroencephalogram (EEG) recordings as they passively viewed a set of 120 pictures. These pictures were selected from the International Affective Picture System 37 and included 30 pleasant, 30 unpleasant and 30 neutral pictures. The fourth picture category (30 pictures) depicted drugs and individuals preparing, using or simulating use of cocaine, as previously described. 18, 19 In accordance with our a priori hypothesis, in this study we report only the results in response to pictures from pleasant, drug and neutral categories (Fig. 1A-C) . Details regarding the J Psychiatry Neurosci 2017;42(2) normative valence and arousal ratings of these pictures and steps involved in EEG signal acquisition and preprocessing are presented in Appendix 1. The number of artifact-free trials used to create averaged ERPs for each condition is included in Appendix 1, Table S1 .
Picture ratings
Immediately following EEG recordings, participants rated each picture on its evocation of cocaine liking (e.g., "Rate how much you like (or do not like) cocaine in response to this picture") and wanting (e.g., "Rate how much you want (or do not want) cocaine in response to this picture"). These ratings were collected with a computerized version of the Self-Assessment Manikin 38 (SAM), for which participants chose the numbers 1 through 9 (9 corresponded to most liking/wanting and 1 corresponded to least liking/wanting) that appeared below the SAM characters.
Attention bias contrasts
The ERP time series in response to neutral pictures were subtracted from those in response to pleasant and drug-related pictures (for normalization purposes). From these difference waveforms, LPP amplitudes were scored as the averaged activity from 400 ms to 2000 ms at the C1, Cz, C2, CP1, CPz and CP2 electrodes. The longer time window (1600 ms) for LPP quantification was chosen as the hypothesis is specific to the overall attention in response to salient cues (during the entire presentation) and the longitudinal changes in attention bias from baseline to 6-month follow-up. Similar or even longer time windows have previously been used to quantify LPP amplitude. 16, 39, 40 Hereafter, these differential scores are referred to as pleasant (i.e., pleasant -neutral) and drug (i.e., drug -neutral) LPP scores. Moreover, differential scores for the drug pictures relative to the pleasant pictures were also created, as done previously 18, 30 as a parameter of attention bias to 2 salient reinforcers; a similar contrast, evaluating drugtaking behaviour in the presence of another concurrently available salient nondrug alternative, is used in drug choice procedures across species [41] [42] [43] and mirrors the addiction diagnostic criterion of using the drug of choice to the exclusion of other activities. 44 
Statistical analysis
We analyzed longitudinal effects in individuals with CUD using a pictures (pleasant v. drug) × time (baseline v. follow-up) CUD, follow-up B 2 × 2 repeated-measures analysis of variance (ANOVA), in which both pictures and time were entered as within-group factors. As a targeted test of our "reallocation of attention" hypothesis, we also examined the a priori-defined differential (drug -pleasant) scores using a paired t test (baseline v. follow-up). Subsequently, to ascertain whether effects reflected a normalization of function, healthy controls at baseline were compared with individuals with CUD at baseline and separately with individuals with CUD at follow-up on LPP amplitudes using pictures (pleasant v. drug) × group (CUD v. control) 2 × 2 mixed-model analyses of covariance (ANCOVAs), controlling for the effects of depression. Controlling for depression is theoretically justified because severe depression is a comorbid symptom in individuals with CUD; 45 its severity (assessed via BDI) was expectedly significantly higher in individuals with CUD than in controls in the present sample. Analyses with pleasant and drug picture ratings were undertaken to complement the electrocortical results using the same analytical approach. In examining all omnibus effects in the ANOVAs, we applied the Greenhouse-Geisser correction for cases in which sphericity was not met. To localize their source, all significant interactions were followed by independent and paired t tests.
In addition to these ANOVAs, Spearman rank correlation analyses examined associations between the LPP amplitude for each picture category with respective self-reported liking and wanting ratings for cocaine. To specifically assess the hypothesized competition for attentional resources (assessed via ERPs) and its behavioural correlates (assessed via ratings), Spearman correlations examined associations between the LPP amplitude in response to drug-related cues with subjective ratings of pleasant pictures and vice versa. Finally, to test for possible relevance of our main variables to CUD symptomology, Spearman correlations examined associations between differential LPP scores and ratings (i.e., drug -pleasant for both variables) with clinical variables.
Secondary analyses were conducted to investigate the longitudinal stability of our pleasant -neutral and drug -neutral contrasts. We tested whether the raw LPP amplitude in response to neutral pictures also changed from baseline to follow-up using a paired t test. Additionally, to test whether the degree of change in attention bias was affected by a lapse in abstinence, we conducted a pictures (pleasant v. drug) × time (baseline v. follow-up) × lapse (lapsed v. abstinent) mixed ANOVA, with pictures and time as within-subjects factors and lapse as a between-subjects factor. Finally, we investigated the impact of cigarette smoking status on LPP amplitudes using an independent t test, comparing smokers and nonsmokers across diagnosis at baseline. The results of these secondary analyses are reported in Appendix 1.
Results
Participants
We included 19 treatment-seeking individuals with CUD (8 women, mean age 41.7 ± 7.4 yr) and 18 matched healthy controls (5 women, mean age 43.2 ± 6.2 yr) in our study (Table 1) . At baseline, the groups differed on depression (t 26.36 = 2.08, p = 0.048) and cigarette smoking status (11 of 
Longitudinal LPP comparisons in individuals with CUD
In individuals with CUD, the repeated-measures ANOVA revealed a significant pictures × time interaction (F 1,18 = 7.084, p = 0.016), while the main effects did not reach significance (all p > 0.10). Follow-up t tests showed that although LPPs in response to drug-related cues were not different from baseline to follow-up (all p > 0.9), the LPPs in response to pleasant cues significantly increased from baseline to follow-up (t 18 = 2.383, p = 0.028). Further highlighting this finding, the a priori planned comparison for the drug -pleasant LPPs revealed a significant decrease from baseline to follow-up (t 18 = 2.66, p = 0.016). These results indicate a significant change in attention bias: whereas drug-related cues elicited higher LPP amplitude than pleasant cues at baseline, at follow-up this difference was reversed (Table 2; Fig. 1B) .
LPP group comparisons
At baseline, the mixed ANCOVA revealed a significant main effect of pictures (F 1,36 = 13.62, p = 0.001; pleasant > drug) and a significant pictures × group interaction (F 1,36 = 34.37, p < 0.001). Follow-up t tests revealed that compared with healthy controls at baseline, individuals with CUD at baseline showed significantly higher LPPs in response to drug cues (t 35 = 2.92, p = 0.006) and significantly lower activity in response to pleasant cues (t 35 = 4.33, p < 0.001). Furthermore, within-group analyses revealed marginally higher LPP amplitudes to drug cues compared with pleasant cues in individuals with CUD at baseline (t 18 = 1.88, p = 0.08) and significantly higher LPP amplitudes to pleasant cues compared with drug cues in healthy controls (t 18 = 5.75, p < 0.001; Table 2 and Fig. 1B) .
A similar pattern of results emerged when we compared individuals with CUD at follow-up with healthy controls at baseline. The mixed ANOVA revealed a significant main effect of pictures (F 1,35 = 24.45, p < 0.001; pleasant > drug) and a significant pictures × group interaction (F 1,35 = 14.98, p < 0.001). Follow-up independent t tests revealed that individuals with CUD had higher LPPs in response to drug-related cues (t 35 = 2.73, p = 0.010) and lower LPPs in response to pleasant cues (t 35 = 2.12, p = 0.040) at follow-up than healthy controls at baseline. However, unlike at baseline when drug LPPs marginally exceeded pleasant LPPs in individuals with CUD, withingroup analyses at follow-up showed that the mean LPP for pleasant cues was higher (albeit not significantly) than the LPP for drug cues, similar to healthy controls (Table 2 and Fig. 1B) .
Longitudinal rating comparisons in individuals with CUD
In individuals with CUD, the repeated-measures ANOVA revealed a significant main effect of pictures for wanting ratings (F 1,13 = 11.272, p = 0.005; drug > pleasant) but not for liking ratings (p = 0.25). All other interactions and main effects did not reach significance (all p > 0.1). Similarly, the a priori planned comparison between baseline and follow-up for the drug -pleasant ratings did not reveal significant differences for either rating scale (both p > 0.05).
Rating group comparisons
Liking
At baseline, the mixed ANCOVA revealed only a significant main effect of group (F 1,29 = 16.421, p < 0.001; CUD > control) and no other main effects or interactions (all p > 0.05). These results show that individuals with CUD at baseline provided higher liking ratings than healthy controls at baseline for both cocaine and pleasant pictures. A similar pattern emerged at follow-up, as the mixed ANOVA revealed a significant main effect of group (F 1,28 = 10.340, p = 0.003; CUD > control) and a significant pictures × group interaction (F 1,28 = 5.329, p = 0.029); the other main effect did not reach significance (p = 0.59). Follow-up t tests showed that individuals with CUD at 6-month follow-up provided higher liking ratings for cocaine than healthy controls at baseline as they viewed drug (t 18.652 = 3.407, p = 0.003) and pleasant (t 21.690 = 2.664, p = 0.014) pictures. Paired t tests revealed that although healthy controls showed no significant difference in liking of cocaine while viewing drug and pleasant images (p = 0.17), individuals with CUD at follow-up showed higher liking of cocaine while viewing drug images compared with pleasant images (t 14 = 3.984, p = 0.001).
Wanting
At baseline, the mixed ANCOVA revealed a significant main effect of pictures (F 1,31 = 5.031, p = 0.032; drug > pleasant) and a significant pictures × group interaction (F 1,33 = 11.670, p = 0.002), while the main effect of group did not reach significance (p = 0.67). Follow-up t tests to further dissect the interaction showed higher wanting for cocaine while viewing drug images than pleasant images (t 17 = 3.494, p = 0.003).
Similarly, at follow-up the mixed ANOVA revealed a significant main effect of pictures (F 1,30 = 5.225, p = 0.030; drug > pleasant) and a significant pictures × group interaction (F 1,30 = 5.052, p = 0.032), while the main effect of group did not reach significance (p = 0.35). Follow-up t tests to further dissect the interaction showed that at follow-up individuals with CUD showed marginally higher wanting of cocaine while viewing drug images than pleasant images (t 14 = 2.149, p = 0.05).
Correlations
Spearman rank correlation analyses revealed that drugpleasant LPPs negatively correlated with days of abstinence in individuals with CUD at baseline (r s = -0.509, p = 0.026), such that stronger response to drug-related cues relative to pleasant cues was associated with shorter abstinence (i.e., at baseline; Fig. 2A) . The longitudinal change in these drugpleasant cue LPPs between baseline and follow-up [(followup drug -pleasant) -(baseline drug -pleasant)] positively correlated with cocaine craving at follow-up (r s = 0.477, p = 0.045), such that a greater decrease in response to drugrelated cues relative to pleasant cues between baseline and follow-up was associated with lower cocaine craving at follow-up (Fig. 2B) . Furthermore, at baseline, LPPs elicited in response to pleasant cues were negatively correlated with self-reported liking and wanting for cocaine as individuals with CUD viewed drug relative to pleasant cues (liking: r s = -0.575, p = 0.013; wanting: r s = -0.517, p = 0.028), such that the more responsive individuals with CUD were to pleasant cues, the less they liked (Fig. 3A) and wanted (Fig. 3B ) cocaine as they viewed drug-related relative to pleasant cues. The results outlining the effects of confounding factors are presented in Appendix 1.
Discussion
The present longitudinal study shows that the hyposensitivity to non-drug-related positive reinforcers in initially abstinent, treatment-seeking, drug-addicted individuals is ameliorated by sustained reduction of drug use to the extent that the attention bias reverses to favour pleasant non-drug-related reinforcers. Specifically, results demonstrated that at baseline, the attention allocated toward drug-related cues (i.e., the LPP amplitude) was higher than that toward pleasant cues, suggesting increased attention bias toward drug-related cues for individuals with CUD; those with shorter abstinence duration showed higher motivated attention toward drug-related than toward pleasant cues. However, after longer periods of abstinence and/or significantly reduced drug use, the direction of this attention bias reversed such that, in a direct contrast (drug > pleasant), increased motivated attention was allocated toward pleasant cues relative to drug-related cues; the individ uals with CUD who showed a greater reversal toward this pattern (pleasant > drug) also reported decreased cocaine craving at follow-up, suggesting that the reversal in attention bias is associated with recovery from clinical symptomology.
The present study first confirms and extends previous findings of increased motivated attention toward drugrelated cues 7, 8, 17, 19, 20, 24 compared with other non-drug-related reinforcers 30, 46 in individuals with CUD, as evident from increased LPP amplitude as well as increased cocaine wanting while viewing drug-related cues versus pleasant cues. Moreover, the association between the increased liking and wanting for cocaine while viewing drug-related cues and decreased LPP in response to pleasant cues further highlights the notion that chronic drug use reflects the excessive attribution of motivational value to the drug of abuse and its associated cues at the expense of other non-drug-related rewards, consistent with the impaired Response Inhibition and Salience Attribution (iRISA) model of drug addiction. 1, 3 Interestingly, however, following significantly reduced drug use (i.e., at follow-up), results showed reversal of this attention bias such that more attention was afforded to pleasant than to drug-related cues in individuals with CUD, and the extent of this reversal increased with reduced self-reported craving at the follow-up visit. By directly contrasting drugrelated cues with pleasant cues, the observed correlation between the shift in attention bias and lower craving is consistent with prior reports, especially that of a meta-analysis that showed an association between greater attention bias toward drug-related cues and increased self-reported cravings across various substances of abuse (e.g., tobacco, cocaine, alcohol, cannabis, heroin and caffeine). 47 Thus, those who showed greater craving at 6-month follow-up and lower longitudinal change in attention bias as well as greater liking for cocaine while viewing drug-related compared with pleasant pictures at follow-up may be at a greater risk for relapse. Prior studies reported associations between increased attention bias toward drug-related cues and susceptibility to relapse. 11, 12, [29] [30] [31] [32] [33] That relapse status did not have a significant impact on our results is not surprising because in the present study all individuals with CUD showed a significant reduction of drug use (in both abstinent and relapsed subgroups); however, additional longitudinal studies with longer follow-up are required.
Of note, this reversal in attention bias with decreased drug use at follow-up was driven by increased responsiveness to pleasant cues rather than a decrease in reactivity to drugrelated cues, which suggests that maladaptations mediated by chronic drug use that led to hyposensitivity to nondrug-related reinforcers are perhaps more plastic than those that led to hypersensitivity to drug-related cues. This conclusion is further supported by similar results from a prior behavioural study in smokers showing that smokers who maintained abstinence for at least 3 months demonstrated recovery in sensitivity to natural reinforcers compared with current cigarette smokers. 48 Notably, the LPP amplitude in response to neutral pictures did not change significantly from baseline to follow-up (Appendix 1). This result is critical as LPP amplitude for pleasant and drug conditions were extracted from pleasant -neutral and drug -neutral contrasts, respectively, and shows that the effects were not driven by the modulation in LPP amplitude to neutral pictures.
Unlike some previous reports, 25,49 our results did not show a longitudinal decrease in attention afforded to drug-related cues. The lack of attention modulation in response to drugrelated cues has been reported in studies comparing treatment-seeking and non-treatment-seeking individuals with CUD, 50 satiated and abstinent chronic smokers, 51 and short-and long-term abstinent heroin users. 52 These studies suggest that even after longer durations of reduced drug use, responsiveness to drug-related cues stays elevated perhaps owing to longterm pairing of the cues (i.e., pipes of crack-cocaine, other paraphernalia) with the actual drugs. This inability to divert attention away from drug-related cues has been interpreted to mark enhanced personal relevance and could reflect a strong desire to avoid drug-related cues, 53 potentially suggesting an increased motivation to quit/remain abstinent in the present study. Moreover, preclinical and some human studies have shown that cue-induced craving (i.e., craving induced in response to a drug-related cue) incubates during early abstinence time windows 54, 55 before declining at longer abstinence durations in an inverted U-shaped trajectory. 56, 57 Thus, it can be inferred that abstinence durations of individuals with CUD at baseline and at follow-up in the present study were situated on either side of the peak cue-induced craving on the inverted Ushaped curve and therefore resulted in no apparent change in motivated attention to drug-related cues that precedes the craving sensation. However, follow-up studies with assessments at varying abstinence durations are required to adequately delineate the trajectory of motivated attention to drug-related cues in abstaining individuals with CUD.
Limitations
Limitations of the present study include the following. First, our sample size was not large, particularly given the heterogeneity in relapse status. Accordingly, future studies should include a larger sample size to further elucidate the impact of abstinence and relapse on attention bias in treatment-seeking individuals (possibly while also examining changes in attention bias over various periods of reduced drug use). Another limitation of the study was the use of the same stimuli in both sessions, which might have promoted habituation. However, we consider this possibility unlikely, as there was an increase in attention to pleasant cues at follow-up in individuals with CUD, and response to neutral stimuli did not change.
Conclusion
Our study showed that a 6-month period of reduced drug use in individuals with CUD resulted in a reversal in attention bias: whereas at baseline individuals with CUD exhibited more attention to drug-related than to pleasant cues, at follow-up they showed increased attention to pleasant compared with drug-related cues. The associations between this attention bias (drug > pleasant) at baseline and duration of abstinence and between its change (pleasant > drug) at follow-up and self-reported craving suggest that attention bias in addicted individuals could be malleable and may signal clinically meaningful and beneficial outcomes of longerterm abstinence and/or response to treatment. These results therefore further speak to the potential utility of EEG in providing clinically relevant markers of treatment course and its efficacy in drug addiction. Our findings can be directly translated to treatment paradigms, where there could be more emphasis on attaining and cultivating response to nondrug rewards while maintaining abstinence, thereby enhancing the salience of non-drug-related reinforcers to reduce craving and ultimately prevent relapse.
